Fulcrum Therapeutics said it is discontinuing development of pociredir, its experimental oral treatment for sickle cell disease (SCD), after the U.S. Food and Drug Administration (FDA) raised concerns ...

Following a series of sad news in her home country of Nigeria, columnist Oluwatosin Adesoye offers some reflections on grief and loss.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Higher vitamin A levels in the blood were significantly ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google After completing my finals and passing my clinical comprehensive ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Nearly every person with sickle cell disease (SCD) who underwent ...

An experimental, single-dose gene-editing therapy from Tessera Therapeutics successfully corrected the genetic mutation that causes sickle cell disease (SCD) in the majority of blood-forming stem ...

Recently, I doubted I’d be able to write this column. My knees had become swollen, immovable, and painfully untouchable. The slightest movement sent sharp pain through my body. Just sitting up was ...

Newer oral anticoagulants, or blood thinners, were linked to a lower risk of clinically relevant nonmajor bleeding than warfarin, an older blood thinner, in adults with sickle cell disease (SCD) ...

Agios Pharmaceuticals has filed an application with the U.S. Food and Drug Administration (FDA) seeking accelerated approval of mitapivat, its oral therapy for sickle cell disease (SCD). The developer ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google It has been quite some time since I was last here. For that, I ...